跳至主要内容
临床试验/NL-OMON29190
NL-OMON29190招募中不适用

Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia.

eurosis Study Center, Prof. Dr. med. Christian-F. Poets en PD. Dr. med Dirk Bassler, MSc Medical University - Tuebingen GermanyNeurosis study Center, neurosis.studycoordinator@med.uni-tuebingen.de0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Gestational age of 23 0/7-27 6/7 weeks;
  • 2. Postnatal age < 12 hours;

排除标准

  • A clinical decision not to administer therapies (infant not considered viable), dysmorphic features or congenital
  • malformations that adversely affect life expectancy or neurodevelopment and known or suspected congenital
  • heart disease (not including a persistent ductus arteriosus and/or an atrial septum defect). The clinical
  • assessment of dysmorphic features, congenital malformations, suspected congenital heart disease and the
  • decision to exlude an infant for the afore mentioned reasons will be left to the discretion of the attending

研究者

发起方
eurosis Study Center, Prof. Dr. med. Christian-F. Poets en PD. Dr. med Dirk Bassler, MSc Medical University - Tuebingen GermanyNeurosis study Center, neurosis.studycoordinator@med.uni-tuebingen.de

相似试验

进行中(未招募)
1 期
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia - NEUROSISHigh risk of bronchopulmonary dysplasia in very preterm neonatesMedDRA version: 12.1Level: LLTClassification code 10006475Term: Bronchopulmonary dysplasia
EUCTR2009-012203-26-EEniversitätsklinikum Tübingen863
进行中(未招募)
1 期
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia - NEUROSIS
EUCTR2009-012203-26-DEniversity Children's Hospital, Department of Neonatology850
进行中(未招募)
1 期
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary DysplasiaSurvival of extremely Low Birth Weight (ELBW) infants has improved in recent decades but Bronchopulmonary Dysplasia (BPD) remains a major health care problem. BPD is a chronic lung disease that occurs in premature infants requiring mechanical ventilation and oxygen therapy, but also develops in preterm neonates who require little or no ventilatory or oxygen supportMedDRA version: 14.1Level: PTClassification code 10006475Term: Bronchopulmonary dysplasiaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2009-012203-26-BEniversity Children’s Hospital, Department of Neonatology850
进行中(未招募)
1 期
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia - NEUROSIS
EUCTR2009-012203-26-NLniversity Children's Hospital, Department of Neonatology850
进行中(未招募)
1 期
eonatal European Study of Inhaled SteroidsRisk of Bronchopulmonary Dysplasia at Very Preterm InfantsMedDRA version: 14.1Level: PTClassification code 10006475Term: Bronchopulmonary dysplasiaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2009-012203-26-GRniversity Children's Hospital, Department of Neonatology863